GALWAY, IRELAND--December 1, 2016--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharmaceutical major Pfizer (NYSE:PFE) (New York, New York) has axed a planned 400 million euro ($426 million) expansion at its Irish manufacturing operations in Dublin. Within this article: Details axed projects following drug trial failure
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
